Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis

American Journal of Pathology

Volumn 151, Issue 6, 1997, Pages 1751-1758

  Mavilia, Carmelo ^a   Scaletti, Cristina ^a   Romagnani, Paola ^a   Carossino, Anna Maria ^a   Pignone, Alberto ^a   Emmi, Lorenzo ^a   Pupilli, Cinzia ^a   Pizzolo, Giovanni ^b   Maggi, Enrico ^a   Romagnani, Sergio ^a,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Ist Med Int e Immunoallergologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD30 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ARTICLE; CELL DAMAGE; CELL INFILTRATION; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; SKIN BIOPSY; SYSTEMIC SCLEROSIS;

ADULT; ANTIGENS, CD30; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; SKIN; TH2 CELLS;

EID: 15644364960     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Roumm AD, Whiteside TL, Medsger TA, Rodnan GP: Lymphocytes in the skin of patients with progressive systemic sclerosis. Arthritis Rheum 1984, 27:645-653
2. Prescott RJ, Freemont AJ, Jones CIP, Hoyland J, Fielding P: Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 1992, 166:255-263
3. Fleischmajer R, Perlish JS, Reeves JRT: Cellular infiltrates in scleroderma skin. Arthritis Rheum 1977, 20:975-984
4. Lampert IA, Switters AJ, Janossy G, Thomas JA, Palmer S, Gordon-Smith E: Lymphoid infiltrates in skin in graft-versus-host disease. Lancet 1981, 2:1352-1358
5. Gonzalez-Amaro R, Alarcon-Segovia D, Alcocer Varela J, De Leon LD, Rosentstein V: Mononuclear cell-fibroblast interactions in scleroderma. Clin Immunol Immunopathol 1988, 46:412-417
6. Famularo G, Procopio A, Giacomelli R, Danese C, Sacchetti S, Perego MA, Santoni A, Tonietti G: Soluble interleukin 2 receptor, interleukin 2 and interleukin 4 in sera and supernatants from patients with progressive systemic sclerosis. Clin Exp Immunol 1990, 81:368-372
7. Alms WJ, Wigley FM, Wise R: Immunological analysis of broncho alveolar lavage (BAL)cells from scleroderma patients and controls. Arthritis Rheum 1992, 35:S312
8. Needelman BW, Wigley FM, Stair RW: IL-1, IL-2, IL-4, IL-6 TNF-α, IFN-γ levels in sera from patients with scleroderma. Arthritis Rheum 1992, 35:67-72
9. Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K: Demonstration of interleukin 2, interleukin 4 and interleukin 6 in sera from patients with localized scleroderma. Arch Dermatol Res 1995, 287:193-197
10. Mosmann TR, Coffman RL: TH1, and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 7:145-173
11. Romagnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994, 12:227-257
12. Del Prete GF, De Carli M, Almerigogna F, Daniel KC, Zancuoghi MM, Vinante E, Pizzolo G, Romagnani S: Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 1995, 9:81-86
13. Bengtsson A, Johansson C, Linder MT, Hallden G, van der Ploeg I, Scheynius A: Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation. J Leukocyte Biol 1995, 58:683-689
14. Chilosi M, Facchetti F, Notarangelo LD, Romagnani S, Del Prete GF, Almerigogna F, De Carli M, Pizzolo G: CD30 cell expression, and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition. Eur J Immunol 1996, 26:329-334
15. Smith CA, Gruss H-J, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, Grabstein H, Gliniak B, McAllister IB, Fanslow W, Alderson M, Falk B, Gimpel S, Gillis S, Din WS, Goodwin R, Armitage RJ: CD30 antigen, a marker for Hodgkin's lymphoma: is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993, 73:1349-1360
16. D'Elios MM, Romagnani P, Scaletti C, Annunziato F, Manghetti M, Mavilia C, Parronchi P, Pupilli C, Pizzolo G, Maggi E, Del Prete GF, Romagnani S: In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells. J Leukocyte Biol 1997, 61:539-544
17. Del Prete GF, De Carli M, D'Elios MM, Maestrelli P, Ricci M, Fabbri L, Romagnani S: Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993, 23:1445-1449
18. Maggi E, Mazzetti M, Ravina A, Annunziato F, De Carli M, Piccinni MP, Manetti R, Carbonari M, Pesce AM, Del Prete GF, Romagnani S: Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 1994, 265:244-248
19. Maggi E, Giudizi M-G, Biagiotti R, Annunziato F, Manetti R, Piccinni MP, Parronchi P, Sampognaro S, Giannarini L, Zuccati G, Romagnani S: Th2-like CD8+ cells showing B cell helper function, and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 1994, 180:489-495
20. Pupilli C, Brunori M, Misciglia N, Selli C, lanni L, Yanagisaw M, Mannelli M, Serio M: Presence and distribution of endothelin-1 gene expression in human kidney. Am J Physiol 1994, 267:F679-F687
21. Pupilli C, Ariel Gomez R, Tuttle JB, Peach MJ, Carey RM: Spatial association of renin-containing cells and nerve fibers in developing rat kidney. Pediatr Nephrol 1991, 5:690-695
22. Pizzolo G, Vinante F, Morosato L, Nadali G, Chilosi M, Gandini G, Sinicco A, Raiteri R, Semenzato G, Stein H, Pizzolo G: High serum level of soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 1994, 8:741-745
23. Del Prete GF, Maggi E, Pizzolo G, Romagnani S: CD30, Th2 cytokines, and HIV infection: a complex and fascinating link. Immunol Today 1995, 16:76-80
24. D'Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D, Telford JL, Romagnani S, Del Prete GF: Th1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 1997, 158:962-967
25. Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S: Type 1 T helper (Th1)-cell predominance, and IL-12 expression in the gut of patients with Crohn's diseases. Am J Pathol 1997, 150:823-832
26. de Wit D, Van Mechelen M, Zanin C, Dautrelepont J-M, Velu T, Géerard C, Abramowicz D, Scheerlink JP, De Baetselier P, Urbain J, Leo O, Goldman M, Moser M: Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol 1993, 150:361-363
27. Finkelman FD: Relationships among antigen presentation, cytokines, immune deviation and autoimmune diseases. J Exp Med 1995, 182: 279-382
28. van der Heijden FL, Wierenga EA, Bos JD, Kapsenberg ML: High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991, 97:389-394
29. Nakamura T, Lee RK, Nam SY, AI-Ramadi BK, Koni PA, Bottomly K, Podack ER, Flavell RA: Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-g. J Immunol 1997, 158:2090-2098
30. Annunziato F, Manetti R, Cosmi L, Galli G, Heusser CH, Romagnani S, Maggi E: Opposite role for interleukin-4 and interferon-γ on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells. Eur J Immunol 1997, 27:2239-2244
31. Hamann D, Hilkens CMU, Grogan JL, Lens SMA, Kapsenberg ML, Yazdanbakhsh M, van Lier RAW: CD30 expression does not discriminate between human Th 1-, and Th2-type T cells. J Immunol 1996, 156:1387-1391
32. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JP, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK, Holgate ST: Interleukin 4 is localized, and released by human mast cells. J Exp Med 1992, 176:1381-1386
33. White, B: Pathogenesis: immune aspects. Systemic Sclerosis. Edited by PJ Clements, ED Furst. Baltimore, Williams and Wilkins, 1996, pp 229-250
34. Klein NJ, Rigley KP, Callard RE: IL-4 regulated the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells: relationship between vimentin and IL-4. Int Immunol 1992, 5:293-302
35. Postletwaite AE, Holness MA, Katai H, Raghow R: Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 1992, 90:1479-1485
36. Gustafsson R, Fredens K, Nettelbladt O, Hallgren R: Eosinophil activation in systemic sclerosis. Arthritis Rheum 1991, 34:412-422
37. Cox D, Earle L, Jimenez SA, Leiferman KM, Gleich GJ, Varga J: Elevated levels of eosinophil major basic protein in the sera of patients with systemic sclerosis. Arthritis Rheum 1995, 38:939-945
38. White B: Immunologic aspects of scleroderma. Curr Opin Rheumatol 1994, 6:612-615
39. Reiner SL, Seder RA: T helper cell differentiation in immune response. Curr Opin Immunol 1995, 7:360-366
40. Brunner T, Heusser CI, Dahinden CA: Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993, 177:605-612
41. Yashimoto T, Paul WE: CD4pos, NK1.1posT cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 1994, 179:1285-1295
42. Croft M, Swain SL: Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. J Immunol 1995, 154:4269-4282
43. + T cells through IL-12 produced by Leisteria-induced macrophages. Science 1993, 260:547-549
44. Manetti R, Parronchi P, Giudizi MG, Piccinni M-P, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulatory factor (interleukin-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993, 177:1199-1204
45. Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognara S, Piccinni M-P, Macchia D, Maggi E, Del Prete GF, Romagnani S: IL-4 and IFNs (α and γ) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol 1992, 149:2977-2984
46. Wenner C, Guler ML, Macatonia SE, O'Garra A, Murphy KM: Roles of IFN-g and IFN-a in IL-12-induced Th1 development. J Immunol 1996, 156:1442-1447
47. Prior C, Haslam PL: In vivo, and in vitro production of Interferon-γ in fibrosing interstitial lung diseases. Clin Exp Immunol 1992, 88:280-287